Table 1.
Patient | Age | Follow up, years |
Pre-RRP PSA, ng/mL |
Pathologic Gleason score |
Pathologic stage |
Postoperative treatment |
---|---|---|---|---|---|---|
193 | 54 | 7.8 | 4.8 | 3+3=6 | pT2a | No |
219 | 66 | 7.0 | 6.5 | 3+3=6 | pT2b | No |
120 | 65 | 8.2 | 5.9 | 4+4=8 | pT2a | No |
125 | 68 | 8.0 | 5.8 | 3+3=6 | pT2a | No |
335 | 67 | 7.2 | 4.9 | 3+3=6 | pT2b | No |
393 | 61 | 8.0 | 5.0 | 3+4=7 | pT2b | No |
157 | 70 | 6.9 | 5.5 | 3+4=7 | pT2b | No |
190 | 70 | 5.1 | 6.3 | 3+4=7 | pT2b | No |
394 | 46 | 3.8 | 5.7 | 3+3=6 | pT2a | No |
9458 | 61 | 10.0 | 15.0 | 3+2=5 | pT2c | No |
S569 | 61 | 10.1 | 6.9 | 3+4=7 | pT2c | No |
S1576 | 56 | 10.2 | 6.7 | 3+3=6 | pT2a | No |
S2278 | 56 | 10.4 | 4.1 | 5+4=9 | pT2b | No |
S9956 | 66 | 7.1 | 6.2 | 3+3=6 | pT2c | No |
A3181 | 63 | 6.4 | 1.5 | 3+3=6 | pT2c | No |
A6815 | 66 | 5.1 | 9.2 | 3+3=6 | pT2a | No |
9082 | 56 | 7.9 | 5.3 | 3+4=7 | pT2c | No |
8802 | 44 | 11.1 | 1.7 | 3+3=6 | pT2c | No |
5644 | 61 | 5.6 | 7.3 | 3+3=6 | pT2a | No |
9569 | 68 | 8.2 | 14.7 | 3+4=7 | pT3a | No |
172 | 62 | 0.5 | 10.0 | 3+4=7 | pT3a | Yes |
367A | 61 | 2.0 | 4.3 | 4+3=7 | pT2a | Yes |
475A | 63 | 1.0 | 6.5 | 4+3=7 | pT3c | Yes |
8929 | 61 | 1.9 | 11.2 | 4+5=9 | pT3a | No |
9908 | 56 | 3.0 | 13.4 | 3+2=5 | pT2a | No |
7288 | 59 | 2.0 | 10.0 | 3+4=7 | pT3a | Yes |
0138 | 62 | 2.0 | 8.7 | 3+4=7 | pT3b | Yes |
2209 | 57 | 1.2 | 6.6 | 3+4=7 | pT3a | Yes |
9645 | 46 | 4.4 | 12.2 | 3+4=7 | pT3b | Yes |
3710 | 57 | 5.3 | 27.9 | 4+5=9 | pT3b | No |
4789 | 59 | 6.0 | 7.3 | 4+5=9 | pT2c | No |
7795 | 67 | 1.1 | 3.5 | 3+3=6 | pT2c | No |
2049 | 69 | 0.5 | 5.6 | 4+3=7 | pT3a | Yes |